MétaCan
Menu
← Back to cohort

Bilirubin Nanoparticle as an anti-inflammatory therapy for graft versus host disease

2018· article· en· W2974323877 on OpenAlexaff
Sumedha Pareek, Mao Zhang, Abel Trujillo‐Ocampo, Jinyong Kim, Sangyong Jon, Jin S. Im

Bibliographic record

VenueThe Journal of Immunology · 2018
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsKootenay Association for Science & Technology
Fundersnot available
KeywordsGraft-versus-host diseaseMedicineHematopoietic stem cell transplantationImmunologyRegimenImmune systemBone marrowHaematopoiesisTotal body irradiationStem cellComplicationChemotherapyInternal medicineGastroenterologyDiseaseCyclophosphamideBiology

Abstract

fetched live from OpenAlex

Abstract Graft versus host disease (GvHD) caused by alloreactive donor lymphocytes is a fatal complication of hematopoietic stem cell transplant (HSCT). Conditioning regimen consisting of chemotherapy and/or radiation given prior to HSCT can cause the initial tissue damage, which triggers the cross-presentation of alloantigens to the donor immune cells. Previous studies have shown that water-soluble PEGylated bilirubin nanoparticles (BRNP) selectively accumulate at the site of inflammation and prevent further tissue damage through scavenging reactive oxygen species. Therefore we, hypothesized that BRNP treatment after conditioning regimen can reduce GvHD by abating the initial tissue damage in HSCT, and investigated therapeutic efficacy of BRNP using murine GVHD model. Sublethally irradiated recipient mice (Balb/c) were infused with 4×106 bone marrow and 1×106 splenic T cells from donor mice (C57/B6) on day 1, and with or without BRNP (10mg/kg) on days 0, 2, and 4. GvHD symptoms were monitored for 60 days, and scored for changes in fur, skin, posture, activity, and weight. Untreated recipient mice (n=9) developed significantly worse GVHD (mean GVHD score=4.667) compared to BRNP treated recipient mice (n=9, mean GVHD score=1.556) (p=0.0028). This translated into the significantly better survival of BRNP treated mice with day 60 survival of 65% as compared to the untreated recipient mice with day 60 survival of 11% (p=0.03). In summary, we show that BRNP treatment can ameliorate clinical GvHD symptoms and improve survival in murine GVHD model. In the future, we plan to investigate the role of reactive oxygen species in GVHD and mechanism of action on anti-GVHD effects by BRNP.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.306
Teacher spread0.281 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Immunology→Same topicHematopoietic Stem Cell Transplantation→French-language works237,207→